Diagnostic Procedures

TMCA Blood Tests

Standard tumor markers cannot detect cancer about a 20% accuracy, which means 80% inaccurate….the only time that tumor markers are useful is if they are elevated and the doctors wants to evaluate the effect of treatment. But, it is again only 20% useful.

Dr. Tsuneo Kobayashi, MD, PhD from Japan has developed a method for detecting cancer with a simple blood test over 30 years ago and by now has accumulated data from over 25,000 people. The Mayo Clinic in Rochester, Minnesota sent Dr Kobayashi over 200 tubes of blood with no information about the patients….they reported his analysis to be 87.5% accurate, more than a PET scan.

This blood test is a set of algorithms, which analyze 3 different sets of blood-derived types of markers: those released from onco-fetal antigen, those associated with onco-placental antigen and growth-related markers released from cancer blood vessels. The test is therefore called, tumor marker combination assay (TMCA).

The first set of markers are released from cancer cells, the second set from the tissues that support the cancer cells (like it’s “nest”) and the third is from the blood vessels that nourish the cancer cells. Without all three of these components, tumors cannot develop and by looking at the various ratios of these 3 different components, it can be determined if someone has nano-grams, micro-grams, miligrams or a gram of cancer.

One gram of cancer is what is considered stage 1 in Western medicine’s classification system….any quantity less, than 1 gram is completely undetectable by any other method and each of the aforementioned quantities (nano-micro-milli) are various stages of “pre-cancer”. There is simply no other method like this available anywhere in the world, especially with this level of accuracy as reported by the Mayo clinic.

The usefulness of the TMCA test is to accurately determine if someone has cancer, hence it is the only true cancer screening test available. The average person has TMCA 3 (micrograms) and many others have TMCA 4 (milligrams). Very few people are TMCA 2 (nano-grams) and less than 0.3% of people have no cancer.

We use this test for people who want to be screened and we also use it after we have completed our therapies and the PET scan is negative….that way we can semi-quantitatively measure the amount of residual cancer. As mentioned, the average person who has never been diagnosed with cancer has micro-grams (TMCA3).

Blood Tests

Blood testing is performed at least weekly and many time more often in order to continually evaluate each patients’ condition metabolically, as well as hormone status and progress.

The initial blood testings that are held in the centre are;
G6PD
LDH
D-Dimer
CEA
Ca 15-3
Ca 125
Ca 19-9
Fasting Insuling
Estrogen
Progesterone
Testesterone
TSH
FT4
FT3
DHEA-S
IGF1

The periodic blood testings that are held weekly are;
LDH
D-Dimer
CEA
Ca 15-3
Ca 125
Ca 19-9
TSH
FT4
FT3
IGF1

Imaging with MRI, PET/CT, ultrasound are utilized periodically to further evaluate progress.

PET/CT Scans

Lorem ipsum dolor sit amet, quaeque omittantur per at, iudico possim eirmod in duo. Omnes fuisset pri eu, ex pri latine oporteat necessitatibus. Solum audiam ad nec. Pri no copiosae lobortis philosophia, ex per autem facete. Ut eum quod esse minim, meis consulatu suscipiantur in est, elitr facete scaevola in ius. Legere delenit mel ad, in eam falli iracundia suscipiantur, an duo veri nonumy semper. Est tempor officiis recusabo ea, utinam disputationi necessitatibus ex vis, latine adipiscing ei his. No usu vero conclusionemque. Usu te legendos indoctum, eros vitae doctus no has, eum vivendum recteque gubergren in.

Enquire about Treatment Options